Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Novartis
Merck
Dow
US Department of Justice
Cerilliant
McKinsey
Johnson and Johnson
Federal Trade Commission
Moodys

Generated: August 23, 2017

DrugPatentWatch Database Preview

Tolazoline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for tolazoline hydrochloride and what is the scope of tolazoline hydrochloride freedom to operate?

Tolazoline hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for tolazoline hydrochloride.

Summary for Generic Name: tolazoline hydrochloride

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Bulk Api Vendors: see list52
Clinical Trials: see list2,260
Patent Applications: see list373
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tolazoline hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
PRISCOLINE
tolazoline hydrochloride
INJECTABLE;INJECTION006403-005Feb 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Novartis
QuintilesIMS
US Department of Justice
McKesson
Boehringer Ingelheim
Farmers Insurance
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot